Anteris Technologies Global (NASDAQ:AVR) Upgraded to “Hold” at Wall Street Zen

Wall Street Zen upgraded shares of Anteris Technologies Global (NASDAQ:AVR) from a sell rating to a hold rating in a report published on Saturday morning.

Several other analysts have also issued reports on AVR. Barclays boosted their price target on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research report on Friday. Lake Street Capital reissued a “buy” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research report on Friday, January 23rd. Wells Fargo & Company assumed coverage on shares of Anteris Technologies Global in a research report on Wednesday, March 11th. They issued an “overweight” rating and a $16.00 price target on the stock. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research report on Friday, March 27th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $16.00.

Anteris Technologies Global Stock Down 0.1%

NASDAQ AVR opened at $7.24 on Friday. The company’s 50 day moving average is $5.95 and its 200-day moving average is $5.36. Anteris Technologies Global has a 12-month low of $2.85 and a 12-month high of $7.49. The firm has a market cap of $704.74 million, a P/E ratio of -3.25 and a beta of 1.32.

Anteris Technologies Global (NASDAQ:AVR) last posted its quarterly earnings results on Tuesday, May 12th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.01). Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. The business had revenue of $0.49 million during the quarter, compared to the consensus estimate of $0.77 million. During the same period last year, the firm earned ($0.61) EPS. Equities analysts expect that Anteris Technologies Global will post -1.14 EPS for the current year.

Institutional Trading of Anteris Technologies Global

Hedge funds and other institutional investors have recently bought and sold shares of the company. JPMorgan Chase & Co. increased its holdings in Anteris Technologies Global by 32.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,417,627 shares of the company’s stock worth $6,379,000 after acquiring an additional 349,299 shares during the period. Russell Investments Group Ltd. increased its holdings in Anteris Technologies Global by 76.9% during the 3rd quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock worth $29,000 after acquiring an additional 2,841 shares during the period. Cetera Investment Advisers increased its holdings in Anteris Technologies Global by 64.7% during the 1st quarter. Cetera Investment Advisers now owns 16,550 shares of the company’s stock worth $92,000 after acquiring an additional 6,500 shares during the period. The Manufacturers Life Insurance Company bought a new stake in Anteris Technologies Global during the 1st quarter worth approximately $111,000. Finally, Bank of New York Mellon Corp increased its holdings in Anteris Technologies Global by 126.3% during the 1st quarter. Bank of New York Mellon Corp now owns 170,653 shares of the company’s stock worth $947,000 after acquiring an additional 95,259 shares during the period.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.